For a 74-year-old woman with one-week lateral upper arm pain without neurologic symptoms, is it appropriate to discontinue celecoxib and start cyclobenzaprine (muscle relaxant) and add topical diclofenac gel?

Your Proposed Treatment Plan is Not Optimal

For this 74-year-old woman with lateral upper arm pain, you should continue celecoxib (or switch to topical diclofenac gel alone) rather than adding cyclobenzaprine, as muscle relaxants lack efficacy evidence in chronic musculoskeletal pain in older adults and carry significant risks in this age group.

Why Cyclobenzaprine Should Be Avoided

The 2020 JAGS guideline explicitly states that muscle relaxants including cyclobenzaprine "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" and are "not favored for chronic pain" given the potential for adverse effects in older adults 1. The 2020 ACP/AAFP guideline found that ibuprofen plus cyclobenzaprine showed no statistically significant pain reduction at 1-7 days compared to placebo (low-certainty evidence) 2.

Critical safety concerns in a 74-year-old:

• Cyclobenzaprine has atropine-like effects causing urinary retention, confusion, and falls risk 3
• The FDA label specifically warns that "in the elderly, the frequency and severity of adverse events associated with the use of cyclobenzaprine...is increased" 3
• CNS depression is particularly problematic in older adults 3

What Actually Works: NSAIDs

Oral NSAIDs

The ACP/AAFP guideline shows moderate-certainty evidence that oral NSAIDs reduce pain (WMD -0.99 cm on 10-cm VAS) and improve physical function (WMD 0.73 cm) at 1-7 days 2. Celecoxib has demonstrated efficacy in musculoskeletal conditions and offers better gastrointestinal safety than non-selective NSAIDs 4, 5.

If celecoxib "isn't helping" after 1 week, consider:

• Dose optimization (up to 200 mg twice daily for osteoarthritis per FDA labeling)
• The pain may not be primarily inflammatory
• Alternative diagnosis needs consideration

Topical NSAIDs: The Better Choice

Topical diclofenac gel is actually an excellent option and should be your primary recommendation 2. Here's why:

• High-certainty evidence shows topical NSAIDs provide treatment satisfaction (OR 5.20) 2
• Moderate-certainty evidence demonstrates pain reduction (WMD -1.08 cm) and improved physical function (WMD 1.66 cm) at 1-7 days 2
• Topical diclofenac specifically showed efficacy for lateral epicondylitis (similar anatomic region) with mean VAS reduction from 3.5 to 2.1 6
• Increased local adverse events (mild skin reactions) but no increase in systemic adverse events compared to carrier 7
• Particularly appropriate for older adults to minimize systemic NSAID exposure 8

Recommended Treatment Algorithm

Option 1 (Preferred): Switch to topical diclofenac gel alone

• Apply to affected area 3-4 times daily
• Avoids systemic NSAID exposure entirely
• Evidence-based for localized upper extremity pain 2, 6

Option 2: Continue oral celecoxib + add topical diclofenac

• Recent 2026 study showed combination oral celecoxib + topical NSAID superior to oral alone for lateral epicondylitis 9
• However, FDA label warns: "Do not use combination therapy with diclofenac sodium topical solution and an oral NSAID unless the benefit outweighs the risk and conduct periodic laboratory evaluations" 8
• Monitor renal function, especially given her age 10, 8

Option 3: Continue celecoxib alone at optimized dose

• If inadequate response after proper dosing trial, reconsider diagnosis
• Rule out: rotator cuff pathology, cervical radiculopathy (though she lacks neurologic symptoms), referred pain

Critical Safety Monitoring in This 74-Year-Old

Given her age and NSAID use:

• Assess renal function before continuing/combining NSAIDs 10, 8
• Check volume status - dehydration increases renal risk 10
• Review medications for ACE inhibitors, ARBs, diuretics (increase renal toxicity risk) 10, 8
• Cardiovascular risk assessment - though celecoxib appears safer than previously thought 5
• GI risk factors - celecoxib offers better safety than non-selective NSAIDs 2, 5

What NOT to Do

• Do not add cyclobenzaprine - no evidence of benefit, significant harm potential in elderly 1, 3
• Do not discontinue celecoxib prematurely - ensure adequate dose and duration trial first
• Do not ignore the possibility of non-inflammatory pain - if NSAIDs fail, the diagnosis may be wrong

Bottom Line

Stop the cyclobenzaprine prescription. Either switch to topical diclofenac gel monotherapy (safest, evidence-based) or continue celecoxib with careful addition of topical diclofenac if needed, with appropriate renal monitoring. The muscle relaxant adds no benefit and substantial risk in this elderly patient 1, 3.